Faculty

Arielle Medford

MD
Attending Physician
Mass General Cancer Center

Dr. Medford obtained her medical degree from the Johns Hopkins University School of Medicine. She completed internal medicine residency at the Massachusetts General Hospital (MGH), where she won several awards including the Harvard Medical School Resident Teaching Award and the MGH Humanism in Medicine Award. She subsequently returned to the MGH to serve as Chief Resident. She completed her medical oncology fellowship at the Dana Farber Cancer Institute/Mass General Cancer Center, where she also became a clinical post-doctoral fellow at the Broad Institute of Harvard & MIT. She is now an attending medical oncologist at the Mass General Brigham Cancer Institute/Harvard Medical School. Her research focuses primarily on the clinical-translational applications of circulating tumor DNA in early and advanced breast cancer, and how these tools can be used to lead to more personalized care for individual patients living with breast cancer. Dr. Medford is a recipient of the Young Investigator Award from the ASCO Conquer Cancer Foundation and a Paul Calabresi K12 Career Development Award.

2026 Sessions

Should We Order ctDNA in the Adjuvant Setting for Early-Stage Breast Cancer Outside of Clinical Trials?: Yes vs No

  • Moderator
    • Kelly McCann
  • Presenter
    • Arielle Medford
    • Jason Mouabbi
Breast Cancers

No

  • Debate Speaker
    • Arielle Medford
Breast Cancers
Back to top